Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD
Conclusions Roflumilast N-oxide may mitigate epithelial–mesenchymal transition in bronchial epithelial cells in vitro.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: Chronic Obstructive Pulmonary | Drugs & Pharmacology | Respiratory Medicine | Smokers | Study